Welcome to
On Feet Nation
dnna mayugh Online
Thurman Online
Frederick Online
Gennova Biopharmaceuticals, a Pune-based pharmaceutical company, has submitted phase 2 trial data of its mRNA COVID-19 vaccine for approval. The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) is expected to review the data soon.
Gennova Biopharmaceuticals has also completed the recruitment of phase 3 clinical trial data. The pharma company has also developed the mRNA vaccine for the Omicron variant of COVID-19 that will be tested on humans for efficacy & immunogenicity soon.
Read more at https://www.jagranjosh.com/current-affairs/gennova-submits-phase-2-...
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation